Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Dementia01:30

Dementia

726
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
726

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2015
Same author

Development of the human fetal hippocampal formation during early second trimester.

NeuroImage·2015
Same author

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2015
Same author

Imaging in StrokeNet: Realizing the Potential of Big Data.

Stroke·2015
Same author

The Image and Data Archive at the Laboratory of Neuro Imaging.

NeuroImage·2015
Same author

Structural Brain Changes in Early-Onset Alzheimer's Disease Subjects Using the LONI Pipeline Environment.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2015

Related Experiment Video

Updated: Apr 11, 2026

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.9K

Sharing data in the global alzheimer's association interactive network.

Scott C Neu1, Karen L Crawford1, Arthur W Toga1

  • 1Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90095, USA.

Neuroimage
|June 7, 2015
PubMed
Summary
This summary is machine-generated.

The Global Alzheimer's Association Interactive Network (GAAIN) is advancing Alzheimer's disease research by integrating global data. This network shares research data and tools while protecting data ownership and institutional boundaries.

Keywords:
Data repositoryData sharingFederationGAAINNeuroimaging

More Related Videos

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

2.0K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.5K

Related Experiment Videos

Last Updated: Apr 11, 2026

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.9K
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

2.0K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.5K

Area of Science:

  • Neuroscience
  • Biomedical Informatics
  • Data Science

Background:

  • Alzheimer's disease research generates vast, siloed datasets globally.
  • Sharing these data is crucial for identifying disease causes and trends.
  • Existing data-sharing initiatives face challenges in data ownership and institutional autonomy.

Purpose of the Study:

  • To report progress on the Global Alzheimer's Association Interactive Network (GAAIN).
  • To demonstrate a model for secure, federated data sharing in Alzheimer's research.
  • To facilitate the integration of geographically separated Alzheimer's disease research studies.

Main Methods:

  • Developing a shared network for research data, analysis tools, and computational resources.
  • Implementing policies to honor data ownership and prevent unauthorized distribution.
  • Utilizing query results displayed in graphs and summary tables to protect data while revealing trends.

Main Results:

  • Successful integration of geographically-separated and independently-operated Alzheimer's disease research studies.
  • Demonstrated a method for sharing aggregated data trends without compromising raw data ownership.
  • Established a framework for collaborative Alzheimer's research through a secure network.

Conclusions:

  • The GAAIN model effectively facilitates global Alzheimer's disease data sharing.
  • The network's policies successfully balance data accessibility with data ownership and institutional integrity.
  • Continued development of GAAIN is vital for accelerating Alzheimer's disease research and discovery.